RDY
Dr. Reddy’s Laboratories Ltd
12.50$
+2.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 61.5% | 57.6% | 45.7% | 48.6% | 50.8% | 56.1% | 55.8% | 62.1% | 63.5% | 64.0% | 50.7% | 52.1% | |
| 20.4% | 19.2% | 8.3% | 1.2% | 1.0% | 0.9% | 5.6% | 5.1% | 1.8% | 1.8% | 3.0% | 2.7% | |
| 20.4% | 19.2% | 8.3% | 9.3% | 11.0% | 11.1% | 13.0% | 15.2% | 19.2% | 21.0% | 11.7% | 15.2% | |
| 25.0% | 23.4% | 20.8% | 22.3% | 20.7% | 26.6% | 23.2% | 27.4% | 25.9% | 24.6% | 22.3% | 17.5% | |
| 13.1% | 12.3% | 13.0% | 12.9% | 14.9% | 15.1% | 17.1% | 17.4% | 15.1% | 16.4% | 14.4% | 13.2% | |
| 0.0% | 26.0% | 26.0% | 25.7% | 24.0% | 1,704.7% | 1,572.8% | 21.2% | 20.6% | 19.6% | 19.7% | – | |
| 1.7% | 1.9% | 1.7% | 1.7% | 1.7% | 1.7% | 1.7% | 1.5% | 1.3% | 1.1% | 2.4% | 2.2% | |
| 6.7% | 10.0% | 20.4% | 19.8% | 19.7% | 11.9% | 13.4% | 9.3% | 9.6% | 9.5% | 19.6% | 18.1% | |
| 42.9% | 38.2% | 43.6% | 43.9% | 37.8% | 33.3% | 34.8% | 34.9% | 28.2% | 27.6% | 31.6% | 34.3% | |
| 32.9% | 31.1% | 38.7% | 30.9% | 26.5% | 31.4% | 31.4% | 32.1% | 26.7% | 24.8% | 26.4% | 28.9% | |
| 14.8% | 11.0% | 19.9% | 11.4% | 7.3% | 9.0% | 9.0% | 9.6% | 3.8% | 3.6% | 7.9% | 11.2% | |
| 5.5% | 5.9% | 6.1% | 4.1% | 4.6% | 4.6% | 4.8% | 5.5% | 5.5% | 5.6% | 4.1% | 5.8% | |
| 0.0% | 4.8% | 2.2% | 10.8% | 9.5% | 0.0% | 173.5% | 2.0% | 0.0% | 1.0% | 0.8% | 2.1% | |
| 57.1% | 61.8% | 56.4% | 56.1% | 62.2% | 66.7% | 65.2% | 65.1% | 71.8% | 72.4% | 67.6% | 65.1% | |
| 42.9% | 47.9% | 49.2% | 50.5% | 57.1% | 62.1% | 58.8% | 60.0% | 67.0% | 68.5% | 64.1% | 60.8% | |
| 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 27.1% | 22.9% | 0.3% | 0.3% | 0.2% | 0.2% | 0.1% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.